Par Drugs And Chemicals
Par Drugs And Chemicals Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Par Drugs And Chemicals Limited, framed against the sector median so the premium or discount is obvious at a glance.
Par Drugs And Chemicals Limited trades at a P/E of 8.55×.
Valuation
Profitability
Growth
Financial Health
Par Drugs And Chemicals Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Par Drugs And Chemicals Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Par Drugs And Chemicals Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Par Drugs And Chemicals Limited, switchable between annual and quarterly views, consolidated or standalone.
Par Drugs And Chemicals Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,14,02,70,618.12 Cr and reported EPS of ₹10.65.
Par Drugs And Chemicals segment analysis: revenue and profit mix.
Disclosed business segments at Par Drugs And Chemicals with their share of revenue and profit, switchable between consolidated and standalone reporting.
Par Drugs And Chemicals discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Par Drugs And Chemicals Limited.
Our AI distills the core fundamental drivers supporting Par Drugs And Chemicals Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Par Drugs And Chemicals Limited's investment case rests on 9 positive markers and 8 flagged concerns drawn from the latest reported filings.
What you're getting.
The company boasts a debt-to-equity ratio of 0.00, indicating a completely debt-free balance sheet, which is a significant financial strength and reduces financial risk.
Promoter holding stands at a robust 73.4%, demonstrating high confidence from the management in the company's future prospects and stability.
Par Drugs & Chemicals Ltd reported a substantial 31.60% growth in quarterly profit, showcasing strong recent operational performance and profitability.
With a low Price-to-Earnings (P/E) ratio of 8.78, the company appears significantly undervalued compared to its industry peers, suggesting potential for re-rating.
The company exhibits strong profitability with a Return on Capital Employed (ROCE) of 18.40% and Return on Equity (ROE) of 13.60%, indicating efficient capital utilization.
What can break it.
The current price of 101.00 is considerably lower than its 52-week high of 348.00, indicating substantial price volatility and investor sentiment shifts.
The absence of FII and DII holdings (0.00% for both) suggests a lack of institutional confidence or awareness, potentially limiting future capital inflows.
The company has a 0.00% dividend yield, which might deter income-focused investors looking for regular returns from their equity investments.
With a market cap of 124.00 Cr, the company is a small-cap entity, which can lead to lower liquidity and higher susceptibility to market fluctuations.
The company faces stiff competition from larger, more established players in the pharmaceutical sector like Sun Pharma and Cipla, potentially limiting market share.
What would change my mind.
Trim if P/E re-rates above 11. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Par Drugs And Chemicals Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Par Drugs And Chemicals Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Par Drugs And Chemicals Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Par Drugs And Chemicals Limited — derived from the live tape, not yesterday's close.
Par Drugs And Chemicals Limited last traded at ₹92.67 with an intraday range of ₹92.47–₹96.47 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹92.67| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 103.27 | +10.60 | +11.44% |
| R3 | 99.27 | +6.60 | +7.12% |
| R2 | 97.87 | +5.20 | +5.61% |
| R1 | 95.27 | +2.60 | +2.81% |
| PIVOT | 93.87 | 1.20 | 1.29% |
| CURRENT | 92.67 | — | — |
| S1 | 83.27 | -9.40 | -10.14% |
| S2 | 87.27 | -5.40 | -5.83% |
| S3 | 89.87 | -2.80 | -3.02% |
| S4 | 91.27 | -1.40 | -1.51% |
PAR is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 94.4 ~ 94.4
Trading Below opening range, showing Bearishness
Par Drugs And Chemicals Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Par Drugs And Chemicals Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Par Drugs And Chemicals Limited stood at 89.3% of traded volume, against a 20-day average of 71.0%.
Par Drugs And Chemicals announcements: results, concalls, ratings, M&A.
Filings Par Drugs And Chemicals sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Par Drugs And Chemicals files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 49 documents below.
Action(s) taken or orders passed
Par Drugs And Chemicals Limited has informed the Exchange about Action(s) taken or orders passed
Action(s) initiated or orders passed
Par Drugs And Chemicals Limited has informed the Exchange about Action(s) initiated or orders passed
Copy of Newspaper Publication
Par Drugs And Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
Disclosure under SEBI Takeover Regulations
Par Drugs And Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Par Drugs And Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Par Drugs And Chemicals dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Par Drugs And Chemicals has declared, sequenced by announce and record date.
Par Drugs And Chemicals corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Par Drugs And Chemicals Limited: business, sector, key facts.
What Par Drugs And Chemicals Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Par Drugs And Chemicals Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: PAR.
Questions investors ask about Par Drugs And Chemicals Limited (PAR).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Par Drugs And Chemicals Limited (PAR)?
The current share price of Par Drugs And Chemicals Limited (PAR) is ₹92.67. Today, the stock has declined by ₹1.73 (1.83%), trading in a range of ₹92.47 to ₹96.47. The stock opened at ₹94.4 with a trading volume of 5,187 shares.
02Is Par Drugs And Chemicals Limited stock a good investment for long-term?
Par Drugs And Chemicals Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,14,02,70,618.12 crores, P/E ratio of 8.55, ROE of 12.43%, and ROCE of 18.40%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Par Drugs And Chemicals Limited stock?
The 52-week high price of Par Drugs And Chemicals Limited (PAR) is ₹114, while the 52-week low is ₹78.05. Currently trading at ₹92.67, the stock is 40.7% away from its 52-week low and 18.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Par Drugs And Chemicals Limited stock at the current price?
Whether to buy Par Drugs And Chemicals Limited stock at ₹92.67 depends on multiple factors. The stock is currently trading with a P/E ratio of 8.55 and P/B ratio of 0.00. Today's performance shows a loss of 1.83%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Par Drugs And Chemicals Limited and when is the next dividend?
Par Drugs And Chemicals Limited offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹92.67, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Par Drugs And Chemicals Limited?
Par Drugs And Chemicals Limited's key financial metrics include: P/E Ratio: 8.55, P/B Ratio: 0.00, ROE: 12.43%, ROCE: 18.40%, Dividend Yield: 0.00%, EPS: ₹10.65, Book Value: ₹90.52, and Debt-to-Equity: 0.00. The company's market cap stands at ₹1,14,02,70,618.12 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Par Drugs And Chemicals Limited stock performing today in the market?
Par Drugs And Chemicals Limited stock opened at ₹94.4 and is currently trading at ₹92.67, showing a decline of ₹1.73 (1.83%). The intraday high is ₹96.47 and low is ₹92.47. The trading volume stands at 5,187 shares, indicating moderate market participation today.
08What is the P/E ratio of Par Drugs And Chemicals Limited and what does it indicate?
Par Drugs And Chemicals Limited has a Price-to-Earnings (P/E) ratio of 8.55, which means investors are willing to pay ₹8.55 for every ₹1 of earnings. With an EPS of ₹10.65, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Par Drugs And Chemicals Limited (PAR) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy